News from debiopharm group A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( Bloomberg:ALEMK@BB,RICS:ALEMK,ISIN:BE0003843605)

Jun 26, 2014, 11:00 ET

Debiopharm Group and Nobelex Biotech Start Two Collaborations on Development of New Antibiotics Against N. Gonorrhoeae and Enteric Species

Debiopharm Group™ (Debiopharm), a Switzerland-based global biopharmaceutical company developing prescription drugs that target unmet...

Jun 24, 2014, 11:00 ET

Debiopharm Group and TCG Lifesciences Ltd. Announce Successful Completion of First Phase of Research Collaboration on Discovery of Novel Antibiotics

Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription...

May 28, 2014, 08:00 ET

Debiopharm Group™ Moves Forward Three of Its Oncology Clinical Programs and Will Present the Recent Progresses at the 50th American Society of Clinical Oncology (ASCO) Annual Meeting

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs...

May 27, 2014, 02:00 ET

Orient EuroPharma and Debiopharm Group™ Announce Their Partnership and the Launch of Pamorelin® LA in Singapore

Orient EuroPharma Co., Ltd. (Orient EuroPharma) a specialty pharmaceutical company focused in marketing and commercialization with subsidiaries...

May 06, 2014, 03:00 ET

Debiopharm Group™ and Yale University extend and broaden their collaboration for the discovery and development of MIF inhibitors to treat autoimmune and inflammatory diseases

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs...

Apr 08, 2014, 03:30 ET

Curis and Debiopharm Group Report Preclinical Data for Debio 0932 at AACR Annual Meeting 2014

Curis, Inc. (NASDAQ: CRIS), an oncology focused company developing novel, targeted drug candidates for the treatment of human cancers, and...

Apr 02, 2014, 01:30 ET

Evotec and Debiopharm Group™ to Collaborate on Development of New Treatment for Cancer

   - Innovative partnership based on Evotec's Target X projects  - Evotec and Debiopharm to share discovery and...

Mar 06, 2014, 03:00 ET

Debiopharm Group™ to Acquire Products or Companies to Expand Activities at Manufacturing Facility in Martigny (Valais, Switzerland)

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of...

Mar 05, 2014, 09:00 ET

Immunexpress Closes USD 6 Million Financing Round led by Debiopharm Group™

Immunexpress Group (Immunexpress) and Debiopharm Diagnostics SA (Debiopharm), today announced the securing of six million U.S. dollars from a...

Feb 11, 2014, 09:00 ET

Debiopharm Group to Acquire Affinium's Antibiotic Clinical Assets and Platform to Identify and Develop Targeted Antibiotics

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs...

Jan 13, 2014, 11:30 ET

Debiopharm Group Announces Completion of Recruitment for Phase III Clinical Study with Triptorelin 22.5 mg in Central Precocious Puberty

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription...

Jan 08, 2014, 03:00 ET

Spinomix Announces a Milestone Payment from Debiopharm Group™and the Appointment of a new CEO

Spinomix SA, a Swiss company advancing molecular diagnostic through innovative sample preparation technologies and Debiopharm...

Oct 24, 2013, 11:00 ET

Atheris and Debiopharm Group™ to Collaborate for the Lead Optimization of Debio 0826 Using a "Reverse-Discovery" Strategy

Atheris Laboratories, a world leading company in venom-based drug discovery and lead optimization, and Debiopharm Group™ (Debiopharm), a...

Oct 22, 2013, 08:25 ET

Curis and Debiopharm Group™ Announce Initiation of Phase I Dose Finding Clinical Study with a Combination of HSP90 Inhibitor Debio 0932 and Everolimus (Afinitor®)

Curis, Inc. (NASDAQ: CRIS), an oncology focused company developing novel, targeted drug candidates for the treatment of human cancers, and...

Oct 07, 2013, 03:00 ET

Experimental Therapeutics Centre and Debiopharm Group™ to Collaborate for the Development of an Epigenetic Innovative Oncology Target

The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and...

Oct 04, 2013, 04:00 ET

Presented by the Japanese Cancer Association and Debiopharm Group™ The 'JCA Mauvernay Award 2013' goes to Doctors Kitabayashi and Yano

Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that...

Sep 09, 2013, 09:35 ET

Debiopharm Group and TCG Lifesciences Ltd. Enter into an Exclusive Research Agreement to Develop a Novel Class of Antibiotics, a New Strategic Therapeutic Area for Debiopharm

Debiopharm Group (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target...

Sep 05, 2013, 03:00 ET

Go To Market Consulting Inc. and Debiopharm Group Collaborate to Identify Early Stage In-licensing Opportunities on the US West Coast

Go To Market Consulting Inc. (Go To Market), a San Francisco headquartered business development representation and marketing services life...

Sep 02, 2013, 03:00 ET

Debiopharm Group™ Initiates Phase I Dose Escalation Study With Debio 1347 (CH5183284) in Advanced Solid Tumors with FGFR Alterations

Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that...

Aug 29, 2013, 03:00 ET

Debiopharm Group™ Presents the 'Debiopharm Group Life Sciences Award 2013' and two 'Junior Debiopharm Group Life Sciences Awards 2013' During the Annual EPFL SV- Life Science Symposium

Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge